Author/Creator: Kawaguchi, N - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kawaguchi, N

1. P1712Diagnostic performance of coronary flow reserve ratio for the detection of coronary artery disease on 13N-ammonia positron emission tomography. (28th August 2018)

Authors:: Kawamura, G; Okayama, H; Kawaguchi, N; Kido, S; Matsuda, K; Aono, T; Kosaki, T; Hosokawa, S; Tanaka, Y; Shigematsu, T; Kawada, Y; Hiasa, G; Yamada, T; Matsuoka, H; Kazatani, Y
Journal:: European heart journal
Issue:: Volume 39(2018)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. P2698A non-invasive assessment of fractional flow reserve using hybrid 13N-ammonia positron emission tomography/computed tomography coronary angiography. (28th August 2018)

Authors:: Shigematsu, T; Okayama, H; Kawaguchi, N; Fukuyama, N; Iseki, Y; Matsuda, K; Tanaka, Y; Hosokawa, S; Kosaki, T; Kawamura, G; Kawada, Y; Hiasa, G; Yamada, T; Kazatani, Y; Matsuoka, H
Journal:: European heart journal
Issue:: Volume 39(2018)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. Issue 5 (15th April 2005)

Authors:: Nemoto, Y; Kuwabara, S; Misawa, S; Kawaguchi, N; Hattori, T; Takamori, M; Vincent, A
Journal:: Journal of neurology, neurosurgery and psychiatry
Issue:: Volume 76:Issue 5(2005)
Page Start:: 714
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Serum cytokine and chemokine profiles in patients with myasthenia gravis. (9th April 2014)

Authors:: Uzawa, A; Kawaguchi, N; Himuro, K; Kanai, T; Kuwabara, S
Journal:: Clinical and experimental immunology
Issue:: Volume 176:Number 2(2014:May)
Page Start:: 232
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study. (10th August 2020)

Authors:: Uzawa, A; Kojima, Y; Ozawa, Y; Yasuda, M; Onishi, Y; Akamine, H; Kawaguchi, N; Himuro, K; Kuwabara, S
Journal:: Clinical and experimental immunology
Issue:: Volume 202:Number 3(2020)
Page Start:: 321
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗